Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma.
Minna E, Romeo P, De Cecco L, Dugo M, Cassinelli G, Pilotti S, Degl'Innocenti D, Lanzi C, Casalini P, Pierotti MA, Greco A, Borrello MG. Minna E, et al. Among authors: casalini p. Oncotarget. 2014 May 15;5(9):2513-28. doi: 10.18632/oncotarget.1830. Oncotarget. 2014. PMID: 24810336 Free PMC article.
Functional mapping of receptor tyrosine kinases in myxoid liposarcoma.
Negri T, Virdis E, Brich S, Bozzi F, Tamborini E, Tarantino E, Jocollè G, Cassinelli G, Grosso F, Sanfilippo R, Casalini P, Greco A, Pierotti MA, Pilotti S. Negri T, et al. Among authors: casalini p. Clin Cancer Res. 2010 Jul 15;16(14):3581-93. doi: 10.1158/1078-0432.CCR-09-2912. Epub 2010 Jun 3. Clin Cancer Res. 2010. PMID: 20522586 Free article.
CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers.
Turdo F, Bianchi F, Gasparini P, Sandri M, Sasso M, De Cecco L, Forte L, Casalini P, Aiello P, Sfondrini L, Agresti R, Carcangiu ML, Plantamura I, Sozzi G, Tagliabue E, Campiglio M. Turdo F, et al. Among authors: casalini p. Oncotarget. 2016 Oct 25;7(43):69649-69665. doi: 10.18632/oncotarget.11935. Oncotarget. 2016. PMID: 27626701 Free PMC article.
Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies.
Sangaletti S, Tripodo C, Portararo P, Dugo M, Vitali C, Botti L, Guarnotta C, Cappetti B, Gulino A, Torselli I, Casalini P, Chiodoni C, Colombo MP. Sangaletti S, et al. Among authors: casalini p. Oncoimmunology. 2014 Jun 5;3:e28989. doi: 10.4161/onci.28989. eCollection 2014. Oncoimmunology. 2014. PMID: 25083326 Free PMC article.
Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer.
Castagnoli L, Iorio E, Dugo M, Koschorke A, Faraci S, Canese R, Casalini P, Nanni P, Vernieri C, Di Nicola M, Morelli D, Tagliabue E, Pupa SM. Castagnoli L, et al. Among authors: casalini p. J Cell Physiol. 2019 Feb;234(2):1768-1779. doi: 10.1002/jcp.27049. Epub 2018 Aug 21. J Cell Physiol. 2019. PMID: 30132876 Free PMC article.
Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer.
Castagnoli L, Ghedini GC, Koschorke A, Triulzi T, Dugo M, Gasparini P, Casalini P, Palladini A, Iezzi M, Lamolinara A, Lollini PL, Nanni P, Chiodoni C, Tagliabue E, Pupa SM. Castagnoli L, et al. Among authors: casalini p. Oncogene. 2017 Mar 23;36(12):1721-1732. doi: 10.1038/onc.2016.338. Epub 2016 Sep 19. Oncogene. 2017. PMID: 27641338 Free PMC article.
87 results